Méthode en double aveugle : Questions médicales fréquentes

{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Méthode en double aveugle : Questions médicales les plus fréquentes", "headline": "Méthode en double aveugle : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Méthode en double aveugle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-13", "dateModified": "2025-04-08", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Méthode en double aveugle" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Méthodologie en recherche épidémiologique", "url": "https://questionsmedicales.fr/mesh/D015340", "about": { "@type": "MedicalCondition", "name": "Méthodologie en recherche épidémiologique", "code": { "@type": "MedicalCode", "code": "D015340", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.445" } } }, "about": { "@type": "MedicalCondition", "name": "Méthode en double aveugle", "alternateName": "Double-Blind Method", "code": { "@type": "MedicalCode", "code": "D004311", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Hiroyoshi Yajima", "url": "https://questionsmedicales.fr/author/Hiroyoshi%20Yajima", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Miho Takayama", "url": "https://questionsmedicales.fr/author/Miho%20Takayama", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Judith M Schlaeger", "url": "https://questionsmedicales.fr/author/Judith%20M%20Schlaeger", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Nobuari Takakura", "url": "https://questionsmedicales.fr/author/Nobuari%20Takakura", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Ted J Kaptchuk", "url": "https://questionsmedicales.fr/author/Ted%20J%20Kaptchuk", "affiliation": { "@type": "Organization", "name": "Program in Placebo Studies, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Nutritional assessment and medical dietary therapy for management of obesity in patients with non-dialysis chronic kidney disease: a practical guide for endocrinologist, nutritionists and nephrologists. A consensus statement from the Italian society of endocrinology (SIE), working group of the club nutrition-hormones and metabolism; the Italian society of nutraceuticals (SINut), club ketodiets and nutraceuticals \"KetoNut-SINut\"; and the Italian society of nephrology (SIN).", "datePublished": "2024-09-18", "url": "https://questionsmedicales.fr/article/39292364", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s40618-024-02446-8" } }, { "@type": "ScholarlyArticle", "name": "Catheter-based renal denervation in the treatment of arterial hypertension: An expert consensus statement on behalf of the French Society of Hypertension (SFHTA), French Society of Radiology (SFR), French Society of Interventional Cardiology (GACI), French Society of Cardiology (SFC), French Association of Private Cardiologists (CNCF), French Association of Hospital Cardiologists (CNCH), French Society of Thoracic and Cardiovascular Surgery (SFCTCV) and French Society of Vascular and Endovascular Surgery (SCVE).", "datePublished": "2024-09-12", "url": "https://questionsmedicales.fr/article/39332916", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.acvd.2024.05.122" } }, { "@type": "ScholarlyArticle", "name": "Standardized Medical Terminology for Cardiac Computed Tomography 2023 Update: An Expert Consensus Document of the Society of Cardiovascular Computed Tomography (SCCT), American Association of Physicists in Medicine (AAPM), American College of Radiology (ACR), North American Society for Cardiovascular Imaging (NASCI), and Radiological Society of North America (RSNA) with endorsement by the Asian Society of Cardiovascular Imaging (ASCI), the European Association of Cardiovascular Imaging (EACI), and the European Society of Cardiovascular Radiology (ESCR).", "datePublished": "2023-07-25", "url": "https://questionsmedicales.fr/article/37693203", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1148/ryct.230167" } }, { "@type": "ScholarlyArticle", "name": "Standardized assessment of evidence supporting the adoption of mobile health solutions: A Clinical Consensus Statement of the ESC Regulatory Affairs Committee: Developed in collaboration with the European Heart Rhythm Association (EHRA), the Association of Cardiovascular Nursing & Allied Professions (ACNAP) of the ESC, the Heart Failure Association (HFA) of the ESC, the ESC Young Community, the ESC Working Group on e-Cardiology, the ESC Council for Cardiology Practice, the ESC Council of Cardio-Oncology, the ESC Council on Hypertension, the ESC Patient Forum, the ESC Digital Health Committee, and the European Association of Preventive Cardiology (EAPC).", "datePublished": "2024-06-04", "url": "https://questionsmedicales.fr/article/39318699", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1093/ehjdh/ztae042" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Environnement et santé publique", "item": "https://questionsmedicales.fr/mesh/D004778" }, { "@type": "ListItem", "position": 3, "name": "Santé publique", "item": "https://questionsmedicales.fr/mesh/D011634" }, { "@type": "ListItem", "position": 4, "name": "Méthodes épidémiologiques", "item": "https://questionsmedicales.fr/mesh/D004812" }, { "@type": "ListItem", "position": 5, "name": "Méthodologie en recherche épidémiologique", "item": "https://questionsmedicales.fr/mesh/D015340" }, { "@type": "ListItem", "position": 6, "name": "Méthode en double aveugle", "item": "https://questionsmedicales.fr/mesh/D004311" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Méthode en double aveugle - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Méthode en double aveugle", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Méthode en double aveugle", "description": "Comment la méthode en double aveugle aide-t-elle au diagnostic ?\nQuels tests utilisent la méthode en double aveugle ?", "url": "https://questionsmedicales.fr/mesh/D004311?mesh_terms=Consensus&page=521#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Méthode en double aveugle", "description": "Les symptômes sont-ils évalués en double aveugle ?\nComment les symptômes sont-ils mesurés en double aveugle ?", "url": "https://questionsmedicales.fr/mesh/D004311?mesh_terms=Consensus&page=521#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Méthode en double aveugle", "description": "La méthode en double aveugle est-elle utilisée en prévention ?\nComment la prévention est-elle testée en double aveugle ?", "url": "https://questionsmedicales.fr/mesh/D004311?mesh_terms=Consensus&page=521#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Méthode en double aveugle", "description": "Quels traitements utilisent souvent la méthode en double aveugle ?\nPourquoi utiliser la méthode en double aveugle pour les traitements ?", "url": "https://questionsmedicales.fr/mesh/D004311?mesh_terms=Consensus&page=521#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Méthode en double aveugle", "description": "Les complications sont-elles prises en compte en double aveugle ?\nComment les complications sont-elles rapportées ?", "url": "https://questionsmedicales.fr/mesh/D004311?mesh_terms=Consensus&page=521#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Méthode en double aveugle", "description": "La méthode en double aveugle évalue-t-elle les facteurs de risque ?\nComment les facteurs de risque sont-ils pris en compte ?", "url": "https://questionsmedicales.fr/mesh/D004311?mesh_terms=Consensus&page=521#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment la méthode en double aveugle aide-t-elle au diagnostic ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet d'évaluer l'efficacité d'un traitement sans biais d'observation." } }, { "@type": "Question", "name": "Quels tests utilisent la méthode en double aveugle ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des essais cliniques pour tester des médicaments ou des interventions." } }, { "@type": "Question", "name": "Les symptômes sont-ils évalués en double aveugle ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, cela permet d'éviter que les attentes influencent les rapports de symptômes." } }, { "@type": "Question", "name": "Comment les symptômes sont-ils mesurés en double aveugle ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Par des échelles standardisées, sans que les évaluateurs sachent le traitement reçu." } }, { "@type": "Question", "name": "La méthode en double aveugle est-elle utilisée en prévention ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, pour évaluer l'efficacité des vaccins ou des interventions préventives." } }, { "@type": "Question", "name": "Comment la prévention est-elle testée en double aveugle ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "En comparant un groupe recevant le traitement préventif à un groupe placebo." } }, { "@type": "Question", "name": "Quels traitements utilisent souvent la méthode en double aveugle ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les essais de nouveaux médicaments, thérapies ou interventions chirurgicales." } }, { "@type": "Question", "name": "Pourquoi utiliser la méthode en double aveugle pour les traitements ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Pour garantir que les résultats ne soient pas influencés par des attentes ou des biais." } }, { "@type": "Question", "name": "Les complications sont-elles prises en compte en double aveugle ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, pour évaluer les effets indésirables des traitements sans biais." } }, { "@type": "Question", "name": "Comment les complications sont-elles rapportées ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Par des rapports standardisés, sans que les évaluateurs sachent le traitement reçu." } }, { "@type": "Question", "name": "La méthode en double aveugle évalue-t-elle les facteurs de risque ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Indirectement, en contrôlant les variables pour isoler l'effet du traitement." } }, { "@type": "Question", "name": "Comment les facteurs de risque sont-ils pris en compte ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "En randomisant les participants pour équilibrer les caractéristiques entre groupes." } } ] } ] }